Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
5iub | CLR | Adenosine receptor A2a |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
5iub | CLR | Adenosine receptor A2a | / | 1.000 | |
5iu8 | 6DZ | Adenosine receptor A2a | / | 0.795 | |
5iu4 | ZMA | Adenosine receptor A2a | / | 0.769 | |
5iua | 6DX | Adenosine receptor A2a | / | 0.706 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.692 | |
4eiy | ZMA | Adenosine receptor A2a | / | 0.675 | |
5k2c | ZMA | Adenosine receptor A2a | / | 0.659 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.656 | |
3eml | ZMA | Adenosine receptor A2a | / | 0.649 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.644 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.642 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.629 | |
2ydv | NEC | Adenosine receptor A2a | / | 0.582 | |
2ydo | ADN | Adenosine receptor A2a | / | 0.581 | |
4ug2 | NGI | Adenosine receptor A2a | / | 0.560 | |
5g53 | NEC | Adenosine receptor A2a | / | 0.531 | |
4uhr | NGI | Adenosine receptor A2a | / | 0.526 | |
3vg9 | ZMA | Adenosine receptor A2a | / | 0.517 | |
1a4i | NDP | C-1-tetrahydrofolate synthase, cytoplasmic | 1.5.1.5 | 0.498 | |
4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.492 | |
4llk | MEW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.485 | |
3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.482 | |
3pwh | ZMA | Adenosine receptor A2a | / | 0.479 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.477 | |
3uza | T4G | Adenosine receptor A2a | / | 0.477 | |
1so2 | 666 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.471 | |
1fmj | RTL | Retinol dehydratase | / | 0.469 | |
3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.468 | |
4ejn | 0R4 | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.467 | |
1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.465 | |
5dp2 | NAP | CurF | / | 0.465 | |
4jv4 | 1OR | cAMP-dependent protein kinase type I-alpha regulatory subunit | / | 0.464 | |
2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.461 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.461 | |
1upw | 444 | Oxysterols receptor LXR-beta | / | 0.460 | |
1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.460 | |
2y6f | M9F | Isopenicillin N synthase | 1.21.3.1 | 0.460 | |
3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.460 | |
3qpo | PFR | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.460 | |
4ajm | 3A6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.460 | |
1osv | CHC | Bile acid receptor | / | 0.459 | |
2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.459 | |
2rbe | NDP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.459 | |
3h4v | DVP | Pteridine reductase 1 | 1.5.1.33 | 0.459 | |
3kpk | FAD | Sulfide-quinone reductase | / | 0.459 | |
4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.459 | |
3qak | UKA | Adenosine receptor A2a | / | 0.459 | |
3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.458 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.457 | |
3slk | NDP | Polyketide synthase extender module 2 | / | 0.457 | |
4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.457 | |
4ea3 | 0NN | Nociceptin receptor | / | 0.457 | |
1x8b | 824 | Wee1-like protein kinase | 2.7.10.2 | 0.456 | |
4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.456 | |
1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.455 | |
2gjn | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.455 | |
2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.455 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.455 | |
3jsw | JAR | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.455 | |
2y60 | M8F | Isopenicillin N synthase | 1.21.3.1 | 0.454 | |
4equ | G6I | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.454 | |
4g95 | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.454 | |
5hbs | RTL | Retinol-binding protein 1 | / | 0.454 | |
3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
4j6d | TES | Cytochrome P450 monooxygenase | / | 0.453 | |
3uzc | T4E | Adenosine receptor A2a | / | 0.453 | |
1ia4 | TQ6 | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
2bfp | H4B | Pteridine reductase 1 | 1.5.1.33 | 0.452 | |
2gjl | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.452 | |
4b4v | L34 | Bifunctional protein FolD | / | 0.452 | |
4fjz | 4FJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.452 | |
4r21 | STR | Cytochrome P450 family 17 polypeptide 2 | / | 0.452 | |
1fm6 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.451 | |
3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
4at0 | FAD | Possible succinate dehydrogenase | / | 0.451 | |
1fdw | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.450 | |
2ivi | ACW | Isopenicillin N synthase | 1.21.3.1 | 0.450 | |
2wey | EV1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.450 | |
2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.450 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
4bfv | ZVV | Pantothenate kinase | 2.7.1.33 | 0.450 | |
4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.450 | |
1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.449 | |
2iea | TDP | Pyruvate dehydrogenase E1 component | 1.2.4.1 | 0.449 | |
3gwf | FAD | Cyclohexanone monooxygenase | / | 0.449 | |
3iak | EV1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.449 | |
3k3h | BYE | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.449 | |
3kjs | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.449 | |
4ead | 0NP | Thymidine phosphorylase | 2.4.2.4 | 0.449 | |
4j6c | STR | Cytochrome P450 monooxygenase | / | 0.449 | |
4kuh | CAA | 3-hydroxybutyryl-CoA dehydrogenase | / | 0.449 | |
1crb | RTL | Retinol-binding protein 1 | / | 0.448 | |
1e92 | HBI | Pteridine reductase 1 | 1.5.1.33 | 0.448 | |
1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.448 | |
1pd9 | CO4 | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
1qiq | ACC | Isopenicillin N synthase | 1.21.3.1 | 0.448 | |
2bfm | TOP | Pteridine reductase 1 | 1.5.1.33 | 0.448 | |
3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.448 | |
3dyq | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.448 | |
3sl8 | JN7 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.448 | |
4ajf | F03 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.448 | |
4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.448 | |
4l4x | NDP | AmphI | / | 0.448 | |
4lb2 | DM5 | Serum albumin | / | 0.448 | |
4pd6 | URI | Nucleoside permease | / | 0.448 | |
4wa9 | AXI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.448 | |
1l2j | ETC | Estrogen receptor beta | / | 0.447 | |
2dw4 | FAD | Lysine-specific histone demethylase 1A | 1 | 0.447 | |
3oaf | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
4kug | NAD | 3-hydroxybutyryl-CoA dehydrogenase | / | 0.447 | |
1p8d | CO1 | Oxysterols receptor LXR-beta | / | 0.446 | |
1qjf | ACS | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
1u0h | ONM | Adenylate cyclase type 2 | / | 0.446 | |
1u0h | ONM | Adenylate cyclase type 5 | / | 0.446 | |
1xdd | AAY | Integrin alpha-L | / | 0.446 | |
2bel | CBO | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.446 | |
2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
3cwk | REA | Cellular retinoic acid-binding protein 2 | / | 0.446 | |
3zku | HCV | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
1fml | RTL | Retinol dehydratase | / | 0.445 | |
1zg3 | 2HI | Isoflavone 4'-O-methyltransferase | / | 0.445 | |
2g8y | NAD | Hydroxycarboxylate dehydrogenase B | / | 0.445 | |
3d7k | D7K | Benzaldehyde lyase | / | 0.445 | |
3gmd | 2M3 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.445 | |
3up0 | D7S | aceDAF-12 | / | 0.445 | |
1e2j | THM | Thymidine kinase | / | 0.444 | |
1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
1iyz | NDP | Probable quinone oxidoreductase | / | 0.444 | |
2gfs | PQB | Mitogen-activated protein kinase 14 | / | 0.444 | |
2h2q | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.444 | |
2qd5 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.444 | |
3njo | PYV | Abscisic acid receptor PYR1 | / | 0.444 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.444 | |
3znq | SS8 | D-amino-acid oxidase | 1.4.3.3 | 0.444 | |
4a81 | DXC | Major pollen allergen Bet v 1-A | / | 0.444 | |
4a84 | DXC | Major pollen allergen Bet v 1-A | / | 0.444 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
4o1m | NAD | Enoyl-acyl carrier reductase | / | 0.444 | |
4qa0 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.444 | |
4qa2 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.444 | |
1fm4 | DXC | Major pollen allergen Bet v 1-L | / | 0.443 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.443 | |
3g5s | FAD | Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO | / | 0.443 | |
3h4v | NAP | Pteridine reductase 1 | 1.5.1.33 | 0.443 | |
3mpi | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.443 | |
3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.443 | |
3sl6 | JN8 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.443 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
4bge | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.443 | |
1m78 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
1mvs | DTM | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
1qkn | RAL | Estrogen receptor beta | / | 0.442 | |
1rk3 | VDX | Vitamin D3 receptor | / | 0.442 | |
1xkd | NAP | Isocitrate dehydrogenase [NADP] | / | 0.442 | |
2bf7 | HBI | Pteridine reductase 1 | 1.5.1.33 | 0.442 | |
2fsz | OHT | Estrogen receptor beta | / | 0.442 | |
2ivn | ANP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.442 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.442 | |
3qls | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
4bc7 | FAD | Alkyldihydroxyacetonephosphate synthase, peroxisomal | 2.5.1.26 | 0.442 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
4ge4 | 0KE | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 2.6.1.39 | 0.442 | |
4lm4 | JPZ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
1ia3 | TQ5 | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1y2e | 5DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.441 | |
1y5r | C0R | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.441 | |
2f7x | 4EA | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.441 | |
3fnh | JPJ | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.441 | |
3hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.441 | |
4bfu | ZVU | Pantothenate kinase | 2.7.1.33 | 0.441 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
1hb3 | SCV | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
1rx8 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
1soj | IBM | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.440 | |
1w06 | W05 | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
3qfc | NAP | NADPH--cytochrome P450 reductase | / | 0.440 | |
3s7a | 684 | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
4epl | JAI | Jasmonic acid-amido synthetase JAR1 | 6.3.2 | 0.440 | |
4gki | 0JN | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.440 | |
4okx | 198 | Androgen receptor | / | 0.440 |